what are the glp-1 drugs from Gray Market What to Make of the
Description
Conclusions Overall, the study suggested that GLP-1 agonists, particularly liraglutide and semaglutide, were promising options for reducing AUD-related hospitalizations
P = .003), but had lower risk for acute pancreatitis (0.29% vs
The key word in the safety data is "no increase in serious cardiovascular events." That said, the absence of evidence is not evidence of absence
The impact of GLP1 agonists on bone metabolism: A systematic review
That's compared to an overall decline of about 3% in young Americans' use of other types of prescription meds
In short: gastric sleeve results after 1 year show more than double the weight loss of most GLP-1 trials
